Volume 5, Issue 1, March 2020, Page: 5-11
The Lived Experience of Hospitalized Pregnant Women Having Antiphospholipid Syndrome with A Previous Fetal Loss: A Phenomenological Study
Fatma Zaghloul Mahmoud, Maternal and Newborn Health Nursing, Faculty of Nursing, Cairo University, Cairo, Egypt
Yousria Ahmed Elsayed, Maternal and Newborn Health Nursing, Faculty of Nursing, Cairo University, Cairo, Egypt
Abeer Saad Eswi, Maternal and Newborn Health Nursing, Faculty of Nursing, Cairo University, Cairo, Egypt
Received: Sep. 12, 2019;       Accepted: Oct. 17, 2019;       Published: Sep. 3, 2020
DOI: 10.11648/j.rs.20200501.12      View  152      Downloads  33
Abstract
Background: antiphospholipid syndrome is a disorder of the immune system that is characterized by poor obstetric outcome. Women with this disorder may experience devastating problems during pregnancy. Aim: to explore the lived experience of hospitalizedpregnant women having antiphospholipid syndrome with a previous fetal loss. Design: A phenomenological qualitative research design was used with purposive sample of 15 participants. Setting: the high-risk pregnancy department at obstetrics and gynecology hospital which is affiliated to Cairo University Hospitals. Data were collected through semi-structured questionnaire using digital voice recording. Results: uncertainty was the core concept that reflected the experience of the pregnant women under study. This was represented in three major phases: uncertainty before diagnosis with APS, uncertainty after diagnosis, and uncertainty during hospitalization. Seven themes emerged from the data analysis as consequence to uncertainty as follows: living in uncertainty; social burden; psychological suffering; fear of the unknown; stressful hospitalization; threats; and unsettled quality of life. Conclusion: women with antiphospholipid perceived the need to provide them with informational support due to the confused state of mind, threats, lack of knowledge and understanding they expose before and after being diagnosed with APS, and during hospitalization. Recommendation: providing informational support for these women is necessary to meet their needs, improve clinical practice and reduce the negatives consequences of this condition for women during childbearing period.
Keywords
Antiphospholipid Syndrome, Fetal Loss, Qualitative Research
To cite this article
Fatma Zaghloul Mahmoud, Yousria Ahmed Elsayed, Abeer Saad Eswi, The Lived Experience of Hospitalized Pregnant Women Having Antiphospholipid Syndrome with A Previous Fetal Loss: A Phenomenological Study, Rehabilitation Science. Vol. 5, No. 1, 2020, pp. 5-11. doi: 10.11648/j.rs.20200501.12
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Rezk M, Dawood R, Badr H. (2016): Maternal and fetal outcome in women with antiphospholipid syndrome: a three year observational study; The Journal of Maternal-Fetal & Neonatal Medicine. 29 (24).
[2]
Duarte-Garcia A, Pham M, Crowson CS, Moder K, Pruthi R, Matteson EL. (2017): Epidemiology of Antiphospholipid Syndrome: A Population-Based Study [abstract]. Arthritis Rheumatol. 69 (suppl 10). https://acrabstracts.org/abstract/epidemiology-of-antiphospholipid-syndrome-a-population-based-study/Accessed September 8, 2018.
[3]
Rawhya R, Zein E, Rashad A, Ibrahim T, et. al. (2016): Catastrophic Antiphospholipid Syndrome in Egypt: Hindawi Publishing Corporation Case Reports in Rheumatology. Volume 20, Article ID 4161439, 4 pages http://dx.doi.org/10.1155/2016.
[4]
Cervera R. Antiphospholipid syndrome. (2017): Thromb Res. Mar. 151 (1): S43-S47. [Medline].
[5]
Sebastiani GD, Iuliano A, Cantarini L, Galeazzi M. (2016): Genetic aspects of the antiphospholipid syndrome: An update. Autoimmune. Rev 15 (5): 433-9. Doi 10.1016/j.autrev.2016.01.005. Epub 2016 Jan 21.
[6]
Abdel-Wahab N, Lopez-Olivo M, Pinto-Patarroyo GP, Suarez-Almazor ME. (2016): Systematic review of case reports of antiphospholipid syndrome following infection. Lupus. (25), 1520–1531.
[7]
Miyakis S, Lockshin MD, Atsumi T, et. al. (2006): International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost. 4: 295–306.
[8]
Meaney S, Corcoran P, Spillane N, et. al. (2017): Experience of miscarriage: an interpretative phenomenological analysis. BMJ Open. 7: e011382. doi: 10.1136/bmjopen-2016- 011382.
[9]
Sloan A. & Bowe B. (2014). Phenomenology and Hermeneutic Phenomenology: the Philosophy, the Methodologies and Using Hermeneutic phenomenology to investigate Lecturers Experiences of Curriculum Design. Quality & Quantity, 48 (3), 1291-1303.
[10]
Mathew S, Cesario S, Symes L. (2008): Explaining un-explainded perinatal loss. Experiences of women with antiphospholipid syndrome. J Perinat Neonat Nurs. 22: 293-301.
[11]
Georgopoulou s, Efraimidou s, Jane MacLennan s, Ibrahim f, & Cox t. (2015): Antiphospholipid (Hughes) syndrome: Description of population and health related quality of life using the SF-36. lupus; 24, 174-179 http://lup.sagepub.com.
[12]
Radford and Hughes (2015), women’s experiences of early miscarriages: implication of nursing care, Journal ofclinical nursing. 24, 1457–1465 doi: 10.1111/jocn.12781, John Wiley & sons Ltd.
[13]
Abdel Nabi E. (2017). Effect Of Emotional Support On Perceived Stress Among Hospitalized High Risk Pregnant Women. (Unpublished master thesis). Faculty of Nursing, Cairo university.
[14]
De Jesús GR, Rodrigues G, De Jesús NR, & Levy RA. (2014). Pregnancy morbidity in Morbidity in Antiphospholipid Syndrome: What Is the Impact of Treatment? Current Rheumatology Reports, 16 (2), 403.
[15]
Andreoli L, Bertsias GK, Agmon-Levin, Brown s, Cervera R, Costedoat-Chalumeau N Doria A, Fischer-Betz, Forger R et. al. (2017). EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis; 76: 4 doi: 10.1136/annrheumdis-2016-209770.
Browse journals by subject